US OptionsDetailed Quotes

PFE241108C25500

Watchlist

2.49
-0.49-16.44%

15min DelayClose Nov 4 16:00 ET

2.49High2.46Low

Pfizer Stock Discussion

Deep Sea

4 hours ago

$Pfizer (PFE.US)$
According to the Securities Times APP, on November 5, the official website of the National Medical Products Administration (NMPA) showed that Pfizer's talazoparib tosylate capsules (talazoparib) have been approved for marketing. Talazoparib was originally developed by BioMarin, acquired by Medivation from BioMarin in 2015, and Pfizer acquired Medivation for $14 billion in 2016, thus talazoparib belongs to Pfizer since then.

韭菜变主力

18 hours ago

$Pfizer (PFE.US)$ seize every opportunity to sell covered calls. the chart is bearish. The company massively overpaid to acquire Seagan using all cash, as a result they are pay $0.4 per share on interest expense annually. I dislike management who overpays to do M&A and/or share repurchase.

Methods

22 hours ago

$Pfizer (PFE.US)$
10M in volume with over 5B free float.. This will always be a shorts paradise.. Too many outstanding shares for such a cheap stock!🤢🤮